BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30318192)

  • 1. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug.
    Mu Y; Fu Y; Li J; Yu X; Li Y; Wang Y; Wu X; Zhang K; Kong M; Feng C; Chen X
    Carbohydr Polym; 2019 Jan; 203():10-18. PubMed ID: 30318192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-sensitive amphiphilic chitosan-quercetin conjugate for intracellular delivery of doxorubicin enhancement.
    Mu Y; Wu G; Su C; Dong Y; Zhang K; Li J; Sun X; Li Y; Chen X; Feng C
    Carbohydr Polym; 2019 Nov; 223():115072. PubMed ID: 31427010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption.
    Yuan H; Lu LJ; Du YZ; Hu FQ
    Mol Pharm; 2011 Feb; 8(1):225-38. PubMed ID: 21138243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor.
    Feng C; Li J; Mu Y; Kong M; Li Y; Raja MA; Cheng XJ; Liu Y; Chen XG
    Int J Biol Macromol; 2017 Jan; 94(Pt A):170-180. PubMed ID: 27720963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
    Wang X; Chen Y; Dahmani FZ; Yin L; Zhou J; Yao J
    Biomaterials; 2014 Aug; 35(26):7654-65. PubMed ID: 24927684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.
    Qu G; Hou S; Qu D; Tian C; Zhu J; Xue L; Ju C; Zhang C
    Carbohydr Polym; 2019 Mar; 207():428-439. PubMed ID: 30600025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface charge effect on mucoadhesion of chitosan based nanogels for local anti-colorectal cancer drug delivery.
    Feng C; Li J; Kong M; Liu Y; Cheng XJ; Li Y; Park HJ; Chen XG
    Colloids Surf B Biointerfaces; 2015 Apr; 128():439-447. PubMed ID: 25769283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion.
    Yu F; He C; Waddad AY; Munyendo WL; Lv H; Zhou J; Zhang Q
    Drug Dev Ind Pharm; 2014 Jun; 40(6):774-82. PubMed ID: 23679668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ; Liu LN; Du YZ; Yuan H
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration In Vitro and In Vivo.
    Su CW; Chiang MY; Lin YL; Tsai NM; Chen YP; Li WM; Hsu CH; Chen SY
    J Biomed Nanotechnol; 2016 May; 12(5):962-72. PubMed ID: 27305818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin].
    Shen AJ; Xia DN; Gan Y; Li J
    Yao Xue Xue Bao; 2016 Jul; 51(7):1136-43. PubMed ID: 29897223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-mercapto acetyl-N'-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel.
    Huo M; Fu Y; Liu Y; Chen Q; Mu Y; Zhou J; Li L; Xu W; Yin T
    Carbohydr Polym; 2018 Feb; 181():477-488. PubMed ID: 29253998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells.
    Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S
    J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Deoxycholic acid-N,O-hydroxyethyl Chitosan with a Sulfhydryl Modification To Enhance the Oral Absorptive Efficiency of Paclitaxel.
    Yu Y; Huo M; Fu Y; Xu W; Cai H; Yao L; Chen Q; Mu Y; Zhou J; Yin T
    Mol Pharm; 2017 Dec; 14(12):4539-4550. PubMed ID: 29058910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticervical cancer activity of novel pH responsive micelles for oral curcumin delivery.
    Sajomsang W; Gonil P; Saesoo S; Ruktanonchai UR; Srinuanchai W; Puttipipatkhachorn S
    Int J Pharm; 2014 Dec; 477(1-2):261-72. PubMed ID: 25455774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.